drugset / Trial / NCT00267267
A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.
RandomizedParallel-groupDouble-blindTreatment
Summary
The Torcetrapib project was terminated on December 2, 2006 due to safety findings. Cholesterol levels will be measured over six weeks in subjects being treated with two different kinds of combination cholesterol medications to see how the different treatments compare to one another.
Timeline
- Start
- 2006-01
- Primary completion
- —
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | — | — |
| Subject | Ezetimibe | Unknown | — | — |
| Subject | Simvastatin | Small molecule | — | — |
| Subject | torcetrapib | Small molecule | — | — |